Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 938 JPY 1.3%
Market Cap: 26.3B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Cash & Cash Equivalents
ÂĄ11.8B
CAGR 3-Years
2%
CAGR 5-Years
27%
CAGR 10-Years
22%
GNI Group Ltd
TSE:2160
Cash & Cash Equivalents
ÂĄ14B
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
11%
PeptiDream Inc
TSE:4587
Cash & Cash Equivalents
ÂĄ50.4B
CAGR 3-Years
60%
CAGR 5-Years
43%
CAGR 10-Years
31%
Takara Bio Inc
TSE:4974
Cash & Cash Equivalents
ÂĄ40B
CAGR 3-Years
7%
CAGR 5-Years
17%
CAGR 10-Years
8%
S
StemRIM Inc
TSE:4599
Cash & Cash Equivalents
ÂĄ8.4B
CAGR 3-Years
-6%
CAGR 5-Years
27%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Cash & Cash Equivalents
ÂĄ5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
26.3B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
11.8B JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Cash & Cash Equivalents amounts to 11.8B JPY.

What is Pharma Foods International Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
22%

Over the last year, the Cash & Cash Equivalents growth was -33%. The average annual Cash & Cash Equivalents growth rates for Pharma Foods International Co Ltd have been 2% over the past three years , 27% over the past five years , and 22% over the past ten years .

Back to Top